Recent preliminary data in this direction indicate that growth, motility, and complement resistance in several oral Treponema species may be impaired by the administration of a specific oxidoreductase inhibitor (Reed et al. 2018) or that administration of a C3 inhibitor of the alternative complement pathway attenuates the progression of periodontitis (Bostanci et al. 2018). This evidence concerns the gene C3 and periodontitis.